Skip to main content
SpringerLink
Log in

PDGF

  • Reference work entry
  • First Online:
Cancer Therapeutic Targets

  • 1862 Accesses

Abstract

Platelet-derived growth factor (PDGF) is a family of isoforms consisting of homodimers of A-, B-, C-, and D-polypeptide chains and the PDGF-AB heterodimer. The PDGF isoforms stimulate cell proliferation, survival and migration of fibroblasts, smooth muscle cells, pericytes, glial cells, and certain other cell types, via binding to α- and β-tyrosine kinase receptors. Activating mutations of PDGF receptors, or overproduction of PDGF-BB, has been observed in certain tumor types. PDGF has also an important role in the stimulation of cells in the stroma of solid tumors. Targeting of PDGF signaling may thus be of clinical value in tumor treatment.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 649.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 949.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Similar content being viewed by others

References

  • Akiyama H, Kachi S, Silva RL, et al. Intraoccular injection of an aptamer that binds PDGF-B: a potential treatment for proliferative retinopathies. J Cell Physiol. 2006;207:407–12.

    Article  CAS  PubMed  Google Scholar 

  • Andrae J, Gallini R, Betsholtz C. Role of platelet-derived growth factors in physiology and medicine. Genes Dev. 2008;22:1276–312.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Apperley JF, Gardembas M, Melo JV, et al. Response to imatinib mesylate in patients with chronic myeloproliferative diseases with rearrangements of the platelet-derived growth factor receptor beta. N Engl J Med. 2002;347:481–7.

    Article  CAS  PubMed  Google Scholar 

  • Bergers G, Song S, Meyer-Morse N, et al. Benefits of targeting both pericytes and endothelial cells in the tumor vasculature with kinase inhibitors. J Clin Invest. 2003;111:1287–95.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Cao R, Björndahl MA, Religa P, et al. PDGF-BB induces intratumoral lymphangiogenesis and promotes lymphatic metastasis. Cancer Cell. 2004;6:333–45.

    Article  CAS  PubMed  Google Scholar 

  • Chen J, Wall NR, Kocher K, et al. Stable expression of small interfering RNA sensitizes TEL-PDGFbR to inhibition with imatinib or rapamycin. J Clin Invest. 2004;113:1784–91.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Crawford Y, Kasman I, Yu L, et al. PDGF-C mediates the angiogenic and tumorigenic properties of fibroblasts associated with tumors refractory to anti-VEGF treatment. Cancer Cell. 2009;15:21–34.

    Article  CAS  PubMed  Google Scholar 

  • Ding W, Knox TR, Tschumper RC, et al. Platelet-derived growth factor (PDGF)- PDGF receptor interaction activates bone marrow-derived mesenchymal stromal cells derived from chronic lymphocytic leukemia: implications for an angiogenic switch. Blood. 2010;116:2984–93.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Donnem T, Al-Saad S, Al-Shibli K, et al. Prognostic impact of platelet-derived growth factors in non-small cell lung cancer tumor and stromal cells. J Thorac Oncol. 2008;3:963–70.

    Article  PubMed  Google Scholar 

  • Doolittle RF, Hunkapiller MW, Hood LE, et al. Simian sarcoma virus onc gene, v-sis, is derived from the gene (or genes) encoding a platelet-derived growth factor. Science. 1983;221:275–7.

    Article  CAS  PubMed  Google Scholar 

  • Dresemann G, Weller M, Rosenthal MA, et al. Imatinib in combination with hydroxyurea versus hydroxyurea alone as oral therapy in patients with progressive pretreated glioblastoma resistant to standard dose temozolomide. J Neurooncol. 2010;96:393–402.

    Article  CAS  PubMed  Google Scholar 

  • Heinrich M, Coreless CL, Duensing A, et al. Science. 2003;299:708–710.

    Google Scholar 

  • Heldin C-H, Westermark B. Mechanism of action and in vivo role of platelet-derived growth factor. Physiol Rev. 1999;79:1283–316.

    CAS  PubMed  Google Scholar 

  • Hellström M, Kalén M, Lindahl P, et al. Role of PDGF-B and PDGFR-β in recruitment of vascular smooth muscle cells and pericytes during embryonic blood vessel formation in the mouse. Development. 1999;126:3047–55.

    PubMed  Google Scholar 

  • Henriksen R, Funa K, Wilander E, et al. Expression and prognostic significance of platelet-derived growth factor and its receptors in epithelial ovarian neoplasms. Cancer Res. 1993;53:4550–4.

    CAS  PubMed  Google Scholar 

  • Hermanson M, Funa K, Hartman M, et al. Platelet-derived growth factor and its receptors in human glioma tissue: expression of messenger RNA and protein suggests the presence of autocrine and paracrine loops. Cancer Res. 1992;52:3213–9.

    CAS  PubMed  Google Scholar 

  • Jayson GC, Parker GJ, Mullamitha S, et al. Blockade of platelet-derived growth factor receptor-bby CDP860, a humanized, PEGylated di-Fab’, leads to fluid accumulation and is associated with increased tumor vascularized volume. J Clin Oncol. 2005;23:973–81. 2004.

    Article  CAS  PubMed  Google Scholar 

  • Jechlinger M, Sommer A, Moriggl R, et al. Autocrine PDGFR signaling promotes mammary cancer metastasis. J Clin Invest. 2006;116:1561–70.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Kilic T, Alberta JA, Zdunek PR, et al. Intracranial inhibition of platelet-derived growth factor-mediated glioblastoma cell growth by an orally active kinase inhibitor of the 2-phenylaminopyrimidine class. Cancer Res. 2000;60:5143–50.

    CAS  PubMed  Google Scholar 

  • Kitadai Y, Sasaki T, Kuwai T, et al. Expression of activated platelet-derived growth factor receptor in stromal cells of human colon carcinomas is associated with metastatic potential. Int J Cancer. 2006a;119:2567–74.

    Article  CAS  PubMed  Google Scholar 

  • Kitadai Y, Sasaki T, Kuwai T, et al. Targeting the expression of platelet-derived growth factor receptor by reactive stroma inhibits growth and metastasis of human colon carcinoma. Am J Pathol. 2006b;169:2054–65.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Knight ZA, Lin H, Shokat KM. Targeting the cancer kinome through polypharmacology. Nat Rev Cancer. 2010;10:130–7.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Kuhnert F, Tam BY, Sennino B, et al. Soluble receptor-mediated selective inhibition of VEGFR and PDGFRβ signaling during physiologic and tumor angiogenesis. Proc Natl Acad Sci U S A. 2008;105:10185–90.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Loizos N, Xu Y, Huber J, et al. Targeting the platelet-derived growth factor receptor alpha with a neutralizing human monoclonal antibody inhibits the growth of tumor xenografts: implications as a potential therapeutic target. Mol Cancer Ther. 2005;4:369–79.

    CAS  PubMed  Google Scholar 

  • Matei D, Emerson RE, Lai YC, et al. Autocrine activation of PDGFRα promotes the progression of ovarian cancer. Oncogene. 2006;25:2060–9.

    Article  CAS  PubMed  Google Scholar 

  • McArthur GA, Demetri GD, van Oosterom A, et al. Molecular and clinical analysis of locally advanced dermatofibrosarcoma protuberans treated with imatinib: Imatinib Target Exploration Consortium Study B2225. J Clin Oncol. 2005;23:866–73.

    Article  CAS  PubMed  Google Scholar 

  • McCarty MF, Somcio RJ, Stoeltzing O, et al. Overexpression of PDGF-BB decreases colorectal and pancreatic cancer growth by increasing tumor pericyte content. J Clin Investig. 2007;117:2114–22.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Nupponen NN, Paulsson J, Jeibmann A, et al. Platelet-derived growth factor receptor expression and amplification in choroid plexus carcinomas. Mod Pathol. 2008;21:265–70.

    Article  CAS  PubMed  Google Scholar 

  • Ozawa T, Brennan CW, Wang L, et al. PDGFRA rearrangements are frequent genetic events in PDGFRA-amplified glioblastomas. Genes Dev. 2010;24:2205–18.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Paugh BS, Zhu X, Qu C, et al. Novel oncogenic PDGFRA mutations in pediatric high-grade gliomas. Cancer Res. 2013;73:6219–29.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Paulsson J, Sjöblom T, Micke P, et al. Prognostic significance of stromal platelet-derived growth factor b-receptor expression in human breast cancer. Am J Pathol. 2009;175:334–41.

    Article  PubMed  PubMed Central  Google Scholar 

  • Pietras K, Sjöblom T, Rubin K, et al. PDGF receptors as cancer drug targets. Cancer Cell. 2003;3:439–43.

    Article  CAS  PubMed  Google Scholar 

  • Pietras K, Pahler J, Bergers G, et al. Functions of paracrine PDGF signaling in the proangiogenic tumor stroma revealed by pharmacological targeting. PLoS Med. 2008;5:e19.

    Article  PubMed  PubMed Central  Google Scholar 

  • Russell MR, Jamieson WL, Dolloff NG, et al. The a-receptor for platelet-derived growth factor as a target for antibody-mediated inhibition of skeletal metastases from prostate cancer cells. Oncogene. 2009;28:412–21.

    Article  CAS  PubMed  Google Scholar 

  • Sennino B, Falcon BL, McCauley D, et al. Sequential loss of tumor vessel pericytes and endothelial cells after inhibition of platelet-derived growth factor B by selective aptamer AX102. Cancer Res. 2007;67:7358–67.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Seymour L, Dajee D, Bezwoda WR. Tissue platelet-derived growth factor (PDGF) predicts for shortened survival and treatment failure in advanced breast cancer. Breast Cancer Res Treat. 1993;26:247–52.

    Article  CAS  PubMed  Google Scholar 

  • Tamborini E, Miselli F, Negri T, et al. Molecular and biochemical analyses of platelet-derived growth factor receptor (PDGFR) B, PDGFRA, and KIT receptors in chordomas. Clin Cancer Res. 2006;12:6920–8.

    Article  CAS  PubMed  Google Scholar 

  • Uehara H, Kim SJ, Karashima T, et al. Effects of blocking platelet-derived growth factor-receptor signaling in a mouse model of experimental prostate cancer bone metastases. J Natl Cancer Inst. 2003;95:458–70.

    Article  CAS  PubMed  Google Scholar 

  • Verhaak RG, Hoadley KA, Purdom E, et al. Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1. Cancer Cell. 2010;17:98–110.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Waterfield MD, Scrace GT, Whittle N, et al. Platelet-derived growth factor is structurally related to the putative transforming protein p28sis of simian sarcoma virus. Nature. 1983;304:35–9.

    Article  CAS  PubMed  Google Scholar 

  • Xue Y, Lim S, Yang Y, et al. PDGF-BB modulates hematopoiesis and tumor angiogenesis by inducing erythropoietin production in stromal cells. Nat Med. 2012;18:100–10.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Ludwig Institute for Cancer Research, Uppsala University, Uppsala, Sweden

    Carl-Henrik Heldin

Authors
  1. Carl-Henrik Heldin
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Carl-Henrik Heldin .

Editor information

Editors and Affiliations

  1. Division of Hematology & Oncology, Georgetown Lombardi Comprehensive Cancer Center, Georgetown University, Washington, District of Columbia, USA

    John L. Marshall

Rights and permissions

Reprints and permissions

Copyright information

© 2017 Springer Science+Business Media New York

About this entry

Cite this entry

Heldin, CH. (2017). PDGF. In: Marshall, J. (eds) Cancer Therapeutic Targets. Springer, New York, NY. https://doi.org/10.1007/978-1-4419-0717-2_16

Download citation

Publish with us

Policies and ethics

Search

Navigation